NCT03833661 2023-10-25M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)EMD SeronoPhase 2 Completed159 enrolled 23 charts
NCT02178358 2022-02-25A Study of LY2157299 in Participants With Advanced Hepatocellular CarcinomaEli Lilly and CompanyPhase 2 Completed132 enrolled 25 charts